Effects of WT-TP53 and pLXSN on sensitivity of MIA-PaCa-2 pancreatic cancer cells on chemotherapeutic drugs, signal transduction inhibitors and natural products as determined by IC50 analysis.1 Here, TP53 is linked to familial pancreatic carcinoma.